Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2010 1
2011 1
2012 3
2013 6
2014 5
2015 2
2016 1
2017 9
2018 10
2019 5
2020 13
2021 8
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Consensus guidelines for lumbar puncture in patients with neurological diseases.
Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M, Dujmovic I, van der Flier W, Frölich L, Galimberti D, Gnanapavan S, Hemmer B, Hoff E, Hort J, Iacobaeus E, Ingelsson M, Jan de Jong F, Jonsson M, Khalil M, Kuhle J, Lleó A, de Mendonça A, Molinuevo JL, Nagels G, Paquet C, Parnetti L, Roks G, Rosa-Neto P, Scheltens P, Skårsgard C, Stomrud E, Tumani H, Visser PJ, Wallin A, Winblad B, Zetterberg H, Duits F, Teunissen CE. Engelborghs S, et al. Among authors: gnanapavan s. Alzheimers Dement (Amst). 2017 May 18;8:111-126. doi: 10.1016/j.dadm.2017.04.007. eCollection 2017. Alzheimers Dement (Amst). 2017. PMID: 28603768 Free PMC article.
Developing Biomarkers for MS.
Gnanapavan S, Giovannoni G. Gnanapavan S, et al. Curr Top Behav Neurosci. 2015;26:179-94. doi: 10.1007/7854_2014_362. Curr Top Behav Neurosci. 2015. PMID: 25502545 Review.
Can rheumatologists stop causing demyelinating disease?
Baker D, Hadjicharalambous C, Gnanapavan S, Giovannoni G. Baker D, et al. Among authors: gnanapavan s. Mult Scler Relat Disord. 2021 Aug;53:103057. doi: 10.1016/j.msard.2021.103057. Epub 2021 Jun 1. Mult Scler Relat Disord. 2021. PMID: 34126373 Review.
Protecting people with multiple sclerosis through vaccination.
Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J, Marta M, Turner B, Gnanapavan S, Dobson R, Schmierer K, Giovannoni G. Reyes S, et al. Among authors: gnanapavan s. Pract Neurol. 2020 Dec;20(6):435-445. doi: 10.1136/practneurol-2020-002527. Epub 2020 Jul 6. Pract Neurol. 2020. PMID: 32632038 Review.
Science is 1% inspiration and 99% biomarkers.
Dubuisson N, Puentes F, Giovannoni G, Gnanapavan S. Dubuisson N, et al. Among authors: gnanapavan s. Mult Scler. 2017 Oct;23(11):1442-1452. doi: 10.1177/1352458517709362. Epub 2017 May 24. Mult Scler. 2017. PMID: 28537780 Review.
Hidden cost of pembrolizumab therapy.
Gnanapavan S. Gnanapavan S. Mult Scler. 2019 Jun;25(7):1008-1009. doi: 10.1177/1352458518804129. Epub 2018 Oct 12. Mult Scler. 2019. PMID: 30311536 No abstract available.
Tuberculous tales: an East London experience.
Shah AM, Raciborska D, Stevens M, Gnanapavan S, White VLC, Turner B. Shah AM, et al. Among authors: gnanapavan s. Pract Neurol. 2017 Dec;17(6):429-438. doi: 10.1136/practneurol-2017-001653. Epub 2017 Aug 17. Pract Neurol. 2017. PMID: 28819046 Review.
The Evolution of Neurofilament Light Chain in Multiple Sclerosis.
Ferreira-Atuesta C, Reyes S, Giovanonni G, Gnanapavan S. Ferreira-Atuesta C, et al. Among authors: gnanapavan s. Front Neurosci. 2021 Apr 6;15:642384. doi: 10.3389/fnins.2021.642384. eCollection 2021. Front Neurosci. 2021. PMID: 33889068 Free PMC article. Review.
60 results